ArticleThe Journal of biological chemistry2026
Soluble guanylyl cyclase maturation in cells depends on reduction of the incoming heme by a cysteine in the enzyme's beta subunit.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nitric oxide (NO) activates cGMP production by soluble guanylyl cyclase (sGC). To do so, an sGCβ subunit must incorporate heme and form a heterodimer with a partner α subunit. In cells, heme-free (apo) sGCβ obtains heme from glyceraldehyde 3-phosphate dehydrogenase (GAPDH). We recently found that transfer of ferric heme from purified GAPDH to apo-sGCβ was accompanied by heme reduction to ferrous within sGCβ, implicating redox involvement of its Cys residues. Here, we utilized Ser substitutions to probe three conserved, redox active Cys in sGCβ (C78, 122, and 214). Proteins were studied in live HEK293 cells and in purified form. In cells, C78S sGCβ was unique among the variants in being unable to incorporate either added ferric heme or mitochondrially-generated heme, but it did incorporate added ferrous heme-NO and consequently formed an active sGC heterodimer. An internal Cys oxidation event occurred in the wild-type, C122S, and C214S apo-sGCβ proteins during their uptake of ferric heme from GAPDH but did not occur in C78S apo-sGCβ. We conclude: (i) Mitochondrial heme reaching apo-sGCβ in cells is ferric under normal culture conditions. (ii) C78 in the sGCβ subunit provides a reducing equivalent to the incoming ferric heme to reduce it to ferrous and this enables stable heme incorporation. (iii) No other Cys residues in sGCβ or cell thiols can replace the role of C78. Having a protein's heme incorporation rely on an internal Cys redox event is unusual and suggests how sGC maturation may be linked to the thiol redox status in cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.